BiotechTube

FK463

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Candidiasis

Conditions

Candidiasis

Trial Timeline

Feb 27, 1999 → Jan 27, 2002

NCT ID
NCT00036179

About FK463

FK463 is a phase 2 stage product being developed by Astellas Pharma for Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT00036179. Target conditions include Candidiasis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00036179Phase 2Completed
NCT00036166Phase 2Completed

Competing Products

20 competing products in Candidiasis

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
33
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
77
Micafungin + fluconazoleAstellas PharmaPhase 3
77
Micafungin (Mycamine)Astellas PharmaPhase 1
33
Fluconazole + MicafunginAstellas PharmaApproved
85
Micafungin + CaspofunginAstellas PharmaPhase 3
77
Micafungin + FluconazoleAstellas PharmaPhase 3
77
MicafunginAstellas PharmaPhase 2
52
micafungin + caspofunginAstellas PharmaPhase 3
77
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
77
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
77
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
77
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
77
L-743,872MerckPre-clinical
23
CaspofunginMerckPhase 2
52
L-743,872MerckPhase 2
52
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
52
Caspofungin acetate + PlaceboMerckPhase 2
52
Caspofungin + Normal SalineMerckApproved
85
caspofungin acetateMerckPhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85